Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJ, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF. Tabah A, et al. Intensive Care Med. 2012 Dec;38(12):1930-45. doi: 10.1007/s00134-012-2695-9. Epub 2012 Sep 26. Intensive Care Med. 2012. PMID: 23011531
Antimicrobial stewardship of β-lactams in intensive care units.
Cotta MO, Roberts JA, Tabah A, Lipman J, Vogelaers D, Blot S. Cotta MO, et al. Among authors: tabah a. Expert Rev Anti Infect Ther. 2014 May;12(5):581-95. doi: 10.1586/14787210.2014.902308. Epub 2014 Mar 22. Expert Rev Anti Infect Ther. 2014. PMID: 24655303 Review.
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
Tabah A, De Waele J, Lipman J, Zahar JR, Cotta MO, Barton G, Timsit JF, Roberts JA; Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM). Tabah A, et al. J Antimicrob Chemother. 2015 Sep;70(9):2671-7. doi: 10.1093/jac/dkv165. Epub 2015 Jul 13. J Antimicrob Chemother. 2015. PMID: 26169558
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J. Tabah A, et al. Intensive Care Med. 2020 Feb;46(2):245-265. doi: 10.1007/s00134-019-05866-w. Epub 2019 Nov 28. Intensive Care Med. 2020. PMID: 31781835
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO, De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J, Ostermann M, Paiva JA, Schouten J, Sjövall F, Timsit JF, Roberts JA, Zahar JR, Zand F, Zirpe K, De Waele JJ; DIANA study group. De Bus L, et al. Among authors: tabah a. Intensive Care Med. 2020 Jul;46(7):1404-1417. doi: 10.1007/s00134-020-06111-5. Epub 2020 Jun 9. Intensive Care Med. 2020. PMID: 32519003 Free PMC article.
129 results